Bristol Myers Squibb reports $11.49 billion revenue for quarter ended March 31, 2026, up 2.6%
Bristol Myers Squibb reported revenue of $11.49 billion for the quarter ended March 31, 2026, an increase of 2.6% from the same quarter a year earlier ($11.2 billion).
For the same period it posted net income of $2.68 billion, up 9%, or $1.31 per diluted share (1.20 a year earlier).
That is a net margin of 23.3%.
On Sanad's AAOIFI Standard 21 screen, Bristol Myers Squibb is currently not compliant: interest-bearing debt is 34.8% of market capitalisation (limit 30%), and impure income is 1.2% of revenue (limit 5%).
Is Bristol Myers Squibb halal?
See the full AAOIFI screening of Bristol Myers Squibb
See the full AAOIFI screening of Bristol Myers Squibb
Source: 10-Q filed with the U.S. Securities and Exchange Commission on April 30, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.